Head-to-head · Cost-Efficiency Index
Oria Meds vs Blue Haven RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Oria Meds
Readers who want the dispensing pharmacy named with an address and will complete the intake to see the real plan menu.
Visit Oria MedsBlue Haven RX
Shoppers who read the FAQ carefully before trusting the homepage price.
Visit Blue Haven RXThe verdict
Oria Meds takes it, leading the Cost-Efficiency Index 62 to 61. Oria Meds advertises compounded GLP-1s from $149 and $249, then offers $199 and $369 once you reach the plan menu, and never names either molecule on a public page. Blue Haven RX still earns a C — Shoppers who read the FAQ carefully before trusting the homepage price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Oria Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Oria Meds | Blue Haven RX |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 61/100 |
| Semaglutide / mo | $199/month month-to-month (read in the intake; the homepage's $149 appears nowhere in the funnel) | $149/mo (all doses, compounded) |
| Tirzepatide / mo | $369/month month-to-month (the homepage's $249 appears nowhere in the funnel) | $179/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,788 |
| Tirzepatide / yr (modeled) | $4,428 | $2,148 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #219 | #225 |
Oria Meds
62/100Where the value is
- Names its compounding pharmacy, PerfectRx, with a street address, phone number and website
- The monthly figure covers free shipping, a home injection kit, free dose increases and unlimited medical support, itemized on the plan card
- Names the provider network behind the prescriptions rather than referring only to licensed clinicians
The tradeoffs
- Neither published floor exists in the funnel: "starting at $149" and "starting at $249" appear nowhere in the plan menu, which offers $199 and $369
- The semaglutide ladder is inverted — one month is $199 while three and six months are both $209 a month, so committing longer costs more
Blue Haven RX
61/100Where the value is
- Claims flat, dose-independent pricing ('no price increases' regardless of dose)
- Routes to established physician networks (Wasef Health, Beluga Health) rather than an unknown in-house provider
- Payments held until doctor approval, per site copy, reducing risk of paying for a declined prescription
The tradeoffs
- Internal pricing contradiction: homepage says tirzepatide is $179/month, FAQ says $259/month
- No named medical director
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.